TABLE 2.

Tracer Uptake (SUV_BW) in Different Tissues 60–120 Minutes After Injection (n = 3 Each)

Tracer	SCG	Salivary gland	Liver	Blood	Bone	Background
18F-DCFPyL	20.9 ± 8.2	13.2 ± 5.3	78.4 ± 29.4	12.9 ± 3.0	10.5 ± 3.5	3.2 ± 0.7
18F-JK-PSMA-7	31.3 ± 10.5	14.4 ± 2.4	119.3 ± 8.3¶	16.3 ± 4.2	9.9 ± 1.9	4.0 ± 1.0
18F-JK-PSMA-8	14.4 ± 2.6	9.0 ± 2.5	29.0 ± 7.2	8.6 ± 0.3	19.2 ± 2.1	3.2 ± 0.4
18F-PSMA-1007	94.8 ± 19.6*	62.1 ± 14.2†	50.7 ± 4.3	62.6 ± 10.7‖	33.2 ± 9.5#	15.9 ± 1.7**
68Ga-PSMA-11	41.0 ± 3.4	38.4 ± 10.2‡	43.7 ± 14.4	39.6 ± 4.6§	18.5 ± 0.6	9.2 ± 0.6**

^*Significantly higher than any other (F_4,10 = 26.52, P < 0.0001; post hoc P < 0.05).

^†Significantly higher than any other (F_4,10 = 22.06, P < 0.0001; post hoc P < 0.05).

^‡Significantly higher than ¹⁸F-DCFPyL (F_4,10 = 22.06, P < 0.0001; post hoc P < 0.05).

^¶Significantly higher than ¹⁸F-JK-PSMA-8 (¹⁸F-PSMA-1007 and ⁶⁸Ga-PSMA-11. F_4,10 = 7.83, P = 0.0040; post hoc P < 0.05).

^‖Significantly higher than any other (F_4,10 = 47.59, P < 0.0001; post hoc P < 0.05).

^§Significantly higher than ¹⁸F-DCFPyL, ¹⁸F-JK-PSMA-7, and ¹⁸F-JK-PSMA-8 (F_4,10 = 47.59, P < 0.0001; post hoc P < 0.05).

^#Significantly higher than any other (F_4,10 = 12.19, P = 0.0007; post hoc P < 0.05).

^**Significantly different from all others (F_4,10 = 93.81, P < 0.0001; post hoc P < 0.05).